Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $420

Benzinga · 04/14 14:16
Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Hold and lowers the price target from $450 to $420.